Humoral and cellular immune responses against SARS-CoV-2 variants of concern induced by heterologous CoronaVac/ChAdOx-1 versus homologous ChAdOx-1 vaccination in the elderly.,Asian Pacific Journal of Allergy and Immunology

当前位置： X-MOL 学术 › Asian Pac. J. Allergy Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Humoral and cellular immune responses against SARS-CoV-2 variants of concern induced by heterologous CoronaVac/ChAdOx-1 versus homologous ChAdOx-1 vaccination in the elderly.
Asian Pacific Journal of Allergy and Immunology ( IF 5 ) Pub Date : 2023-02-11 , DOI: 10.12932/ap-120822-1434
Chalerm Liwsrisakun ₁ , Supansa Pata _{2,

3} , Witida Laopajon _{2,

3} , Nuchjira Takheaw _{2,

3} , Warawut Chaiwong ₁ , Pilaiporn Duangjit ₁ , Juthamas Inchai ₁ , Kantinan Chuensirikulchai _{2,

3} , Passaworn Cheyasawan ₃ , Chaicharn Pothirat ₁ , Chaiwat Bumroongkit ₁ , Athavudh Deesomchok ₁ , Theerakorn Theerakittikul ₁ , Atikun Limsukon ₁ , Pattraporn Tajarernmuang ₁ , Nutchanok Niyatiwatchanchai ₁ , Konlawij Trongtrakul ₁ , Watchara Kasinrerk _{2,

3}

Affiliation

The concept of heterologous vaccination against SARS-CoV-2 infection has been adopted in Thailand with limited data on the induction of humoral and cellular immunity, particularly the CoronaVac/ChAdOx-1 (CoVac/ChAd) regimen in the elderly.

中文翻译：

老年人异源 CoronaVac/ChAdOx-1 疫苗与同源 ChAdOx-1 疫苗接种引起的针对 SARS-CoV-2 变体的体液和细胞免疫反应。

泰国采用了针对 SARS-CoV-2 感染的异源疫苗接种的概念，但关于诱导体液和细胞免疫的数据有限，尤其是老年人的 CoronaVac/ChAdOx-1 (CoVac/ChAd) 方案。

更新日期：2023-02-11

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>